Bitvio 0.1% Ointment

Bitvio 0.1% Ointment is an ointment with Mometasone furoate 0.1% declared as its active content. It is supplied in a pack size of 20g.

This is a non-prescription product and can be purchased without a prescription. Only product, safety and handling details are published on this page.

An online consultation with a DoctorOnCall doctor or pharmacist is available for this product, and a registered pharmacist reviews each order before dispatch to Malaysia or Singapore. Follow the directions on the label and on the leaflet inside the pack.

Bitvio 0.1% Ointment should be used only as directed by the doctor consulted through DoctorOnCall. A thin layer is typically applied to the affected skin once daily, gently rubbed in until absorbed, and hands should be washed afterward unless the hands are the area being treated. It should not be applied under airtight dressings or bandages unless specifically instructed, as this significantly increases absorption and the risk of side effects.

The dosage, application frequency, and duration of Bitvio 0.1% Ointment must be determined by the prescribing doctor based on the specific skin condition, its location, and severity. Treatment is generally limited to a short course, and continuous use, especially on the face, groin, or in children, is typically avoided or closely monitored due to the increased risk of skin thinning and other steroid-related effects with prolonged application.

Bitvio 0.1% Ointment is generally stable for up to 24 to 36 months from the date of manufacture when the tube remains unopened and is stored correctly; the specific expiry date is printed on the tube and carton. The ointment should not be used past its labelled expiry date, and leftover product from a previous prescription should be checked with a pharmacist before reuse.

Store Bitvio 0.1% Ointment at room temperature, below 30 degrees Celsius, in a cool, dry place away from direct sunlight. Keep the tube tightly closed after each use, and store out of reach and sight of children and pets.

• Known hypersensitivity or allergy to mometasone furoate or any other ingredient in the ointment
• Untreated bacterial, viral, or fungal skin infections at the application site
• Chickenpox, shingles, or other primary viral skin lesions
• Rosacea, perioral dermatitis, or acne vulgaris, which can be worsened by topical corticosteroids
• Use on the face, groin, or armpits for prolonged periods without close medical supervision
• Not recommended for use in the eyes or on mucous membranes

• Avoid using other topical corticosteroid products at the same time without medical advice, as this may increase the overall steroid load and risk of side effects
• Use of occlusive dressings alongside this ointment can significantly increase systemic absorption and side effects
• Inform the prescribing doctor of any other topical treatments, including traditional or herbal remedies, applied to the same area
• No significant food interactions are expected with topical use, as systemic absorption is normally minimal when used as directed

• Complete the DoctorOnCall online consultation so the doctor can confirm this treatment is appropriate for your specific skin condition
• Apply only a thin layer to the affected area and avoid healthy surrounding skin
• Do not use for longer than the prescribed duration, even if the skin appears to have improved
• Avoid covering the treated area with airtight dressings unless specifically instructed
• Follow up with your doctor if the condition does not improve as expected or if it worsens
• Take extra care when applying near the eyes or on thin-skinned areas such as the face

Bitvio 0.1% Ointment is intended for short-term, doctor-supervised treatment of specific inflammatory skin conditions and should not be used as a general moisturiser or for undiagnosed skin complaints. Because it is a potent corticosteroid, ongoing medical supervision helps to balance effective symptom control against the risk of skin thinning and other steroid-related side effects with prolonged use. Customers in Malaysia and Singapore can obtain this medicine through DoctorOnCall after an online consultation confirms it is medically appropriate.